Chronic pain · Sleep · Central sensitisation
Why treating your sleep might be the most effective pain intervention you haven't tried
Chronic pain and poor sleep exist in a bidirectional, mutually reinforcing relationship. Pain disrupts sleep. Disrupted sleep lowers pain thresholds, amplifies central sensitisation, and drives inflammation. Yet standard pain management rarely addresses the sleep component directly — even though the evidence strongly suggests it should.
The neuroscience of pain and sleep
Slow-wave sleep is the phase during which descending pain inhibitory control is most active. When sleep is fragmented — whether from pain, sleep-disordered breathing, periodic limb movements, or any other cause — this inhibitory control is impaired. Central sensitisation increases: previously subthreshold stimuli become painful, pain becomes more widespread, and the patient becomes progressively more difficult to treat with conventional analgesics alone. In fibromyalgia, widespread pain, and ME/CFS, this mechanism is central to the clinical picture. Many patients have demonstrably disrupted sleep architecture on objective testing — yet receive no targeted sleep intervention.
Objective sleep biomarkers in pain medicine
Ambulatory sleep assessment using platforms measuring HRV, cardiopulmonary coupling indices, and sleep quality metrics can provide objective data that symptom questionnaires cannot capture. These indices correlate with autonomic dysfunction and central sensitisation, providing a measurable baseline against which treatment changes can be tracked. In patients with medically unexplained fatigue and pain, quantifying what is happening overnight is an important diagnostic step that standard consultations do not routinely provide.
Opioid-induced sleep disruption
There is a painful irony in opioid prescribing for chronic pain: opioids suppress slow-wave sleep, worsen sleep continuity, and at higher doses cause central sleep apnoea. The medication prescribed to manage pain is directly damaging the sleep architecture that the brain needs in order to suppress pain. Objective sleep monitoring in patients on long-term opioids can quantify this disruption and inform opioid reduction strategies with a concrete physiological rationale.
Key references
- Finan PH et al. The association of sleep and pain: an update and a path forward. J Pain 2013;14(12):1539–1552.
- Roehrs TA et al. Sleep and pain: interactions of two vital functions. Semin Neurol 2012;32(3):285–291.
- Azarbarzin A et al. The hypoxic burden of sleep apnoea. Eur Heart J 2019;40(14):1149–1157.
- Walker JM et al. Sleep and the new biology of pain. J Opioid Manag 2007;3(2):87–93.
No GP referral needed. Available UK-wide. Usually within 1–2 weeks.